Empreendimentos Pague Menos SA
BOVESPA:PGMN3
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.2
3.96
|
| Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Empreendimentos Pague Menos SA
Empreendimentos Pague Menos SA
Cost of Revenue
Empreendimentos Pague Menos SA
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Empreendimentos Pague Menos SA
BOVESPA:PGMN3
|
Cost of Revenue
-R$7.7B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Raia Drogasil SA
BOVESPA:RADL3
|
Cost of Revenue
-R$26.5B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-18%
|
|
|
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
|
Cost of Revenue
-R$3.2B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
|
d
|
d1000 Varejo Farma Participacoes SA
BOVESPA:DMVF3
|
Cost of Revenue
-R$1.2B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Empreendimentos Pague Menos SA
Glance View
Empreendimentos Pague Menos SA engages in the retail of medicine, perfumes, toiletries, beauty products, cosmetics, and skin care products. The company is headquartered in Fortaleza, Ceara and currently employs 25,701 full-time employees. The company went IPO on 2020-09-02. Through a drugstore chain, the Company sells medicines, perfumes, personal care and household products, cosmetics, as well as grocery goods, among others. Additionally, It offers a range of financial services, such as bill collection and credit card issuing. The firm also operates a call center that provides information related to drugs usage.
See Also
What is Empreendimentos Pague Menos SA's Cost of Revenue?
Cost of Revenue
-7.7B
BRL
Based on the financial report for Dec 31, 2023, Empreendimentos Pague Menos SA's Cost of Revenue amounts to -7.7B BRL.
What is Empreendimentos Pague Menos SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-13%
Over the last year, the Cost of Revenue growth was -23%. The average annual Cost of Revenue growth rates for Empreendimentos Pague Menos SA have been -17% over the past three years , -13% over the past five years .
You don't have any saved screeners yet
